Phase 1 trial finds high dose of malaria monoclonal antibody is safe, elicits immune response

Retrieved on: 2025-09-24 20:26:34

Tags for this article:

Click the tags to see associated articles and topics

Phase 1 trial finds high dose of malaria monoclonal antibody is safe, elicits immune response. View article details on hiswai:

Excerpt

None of three adults given the highest study dose of the experimental monoclonal antibody MAM01 before malaria infection had parasites in their ...

Article found on: www.cidrap.umn.edu